A.C. Camargo

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Neuroendocrine tumours1 trial
• Sarcoma1 trial

Phase

• Phase 32 trials

Status

• Recruiting3 trials

Lead sponsor

• Boehringer Ingelheim2 trials
• Grupo Espanol de Investigacion en Sarcomas1 trial

Running trials

• Recruiting

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

  NCT04181970· Grupo Espanol de Investigacion en Sarcomas· Source

  Contact: Celso Mello, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Neuroendocrine tumours1 recruiting
• Sarcoma1 recruiting